Vitamin B12 Deficiency Clinical Trial
Official title:
Relative Bioavailability of Folic Acid and L-5-Methlytetrahydrofolate
Folic acid, a form of the vitamin folate, is added to grain products in Canada to help reduce birth defects. Folic acid is the synthetic form of folate and is very stable (doesn't break down) when added to foods. There are emerging health concerns about chronic folic acid consumption. Recently another more natural form of folate, L-5-methyltetrahydrofolate (L-MTHF) has become available. The investigators plan to conduct a randomized trial in women to determine if supplements containing L-MTHF consumed over three months raises blood folate levels as much as supplements containing folic acid. The investigators hypothesize that L-MTHF will increase red cell folate over 12 weeks to same extent as equimolar folic acid.
The proposed study is a twelve week, cross-sectional, double blind, randomized controlled
trial. The sample population will consist of one-hundred fifty healthy adult volunteers. All
participants will be Malaysian women between eighteen and forty-two years of age. Study
participants will be recruited by word of mouth and through advertisements placed in
hospitals and universities starting in January 2011. Study participants will be randomly
assigned to 1 of 3 treatment groups: 1) 1000ug L-MTHF 2) 1000ug folic acid 3) placebo
(methyl cellulose). All treatments will be given in capsule form. Blood samples will be
collected at baseline, 6 and 12 weeks.
The primary outcome measure is red cell folate. A sample size of 45 subjects per group will
allow us to detect a minimum difference of 100 nmol/L red cell folate assuming an alpha
0.05, a beta of 0.8 a SD of 183 nmol/L. Accounting for a 10% attrition rate we will enroll
50 women per group. The study will be analyzed as intent to treat. Baseline characteristics
and compliance between treatment groups will be compared using a one-way ANOVA for
continuous variables and chi-square analyses for categorical variables. The difference in
measurements between the treatment groups at week 12 will be determined by regression
analysis, controlling for baseline values.
;
Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02270749 -
Vitamin Deficiencies and Suppletion in Morbid Obesity
|
Phase 4 | |
Completed |
NCT02540642 -
Effect of Vitamin B12 Supplementation on Glycaemic Control in Uncontrolled Hyperhomocysteinemic Type 2 Diabetic Patients
|
N/A | |
Completed |
NCT00826657 -
Vitamin B12 Supplementation Study
|
N/A | |
Completed |
NCT00843453 -
Long-term Use of Proton Pump Inhibitors May Cause Vitamin B12 Deficiency in the Institutionalized Elderly
|
N/A | |
Completed |
NCT01661309 -
Supplementary Vitamin B12 Effects on Elevated Homocysteine Levels of Vegetarians - Clinical Trial
|
N/A | |
Completed |
NCT01876329 -
Autoantibodies to Gastric Parietal Cells in Rheumatoid Arthritis Patients
|
N/A | |
Completed |
NCT01876732 -
Impact of Vitamin B12 Replacement on Epogen Dosing and Improvement of Quality of Life in Hemodialysis Patients
|
N/A | |
Active, not recruiting |
NCT00326833 -
How Many Patients Are in Need of Vitamin B12 Injections?
|
Phase 4 | |
Completed |
NCT00467623 -
Holotranscobalamin Remains Unchanged During Pregnancy
|
N/A | |
Completed |
NCT02076347 -
Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin
|
N/A | |
Completed |
NCT01297361 -
The Association Between Religious Origin and Age, and Vitamin B12 and Folic Acid Plasma Levels in Non Jewish Population in Western Galilee
|
N/A | |
Completed |
NCT01136512 -
Metformin Use and Vitamin B12 Deficiency
|
N/A | |
Active, not recruiting |
NCT04048330 -
Periconceptional Surveillance in India
|
||
Completed |
NCT00699478 -
Oral Vitamin B12 Administration for Vitamin B12 Deficiency After Total Gastrectomy
|
Phase 2 | |
Completed |
NCT00279552 -
Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?
|
Phase 2 |